ArticleFrontiers in aging neuroscience2026
Interpretable machine learning model based on multimodal MRI radiomics for Alzheimer's disease diagnosis.
Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Alzheimer's disease (AD), the most common neurodegenerative disorder, is a leading cause of cognitive impairment and dementia in older adults. This study aimed to develop an interpretable machine learning model using multimodal MRI radiomics for the diagnosis of Alzheimer's disease. Materials and methods: A total of 110 subjects (48 AD, 62 healthy control subjects) underwent 3D T1WI, DWI, and T2WI scans. Radiomics features were extracted from eight AD-related brain regions and selected using a three-step approach: variance thresholding, independent Results: Sixteen core radiomics features were retained. Combined-sequence models outperformed single-sequence models, achieving test AUCs of 0.989 and 0.970 for LR and RF, respectively. The LR combined-sequence model achieved an accuracy of 0.882, sensitivity of 0.800, and specificity of 0.947. SHAP analysis identified texture features from the parietal lobe as key contributors. A nomogram integrating radiomics and clinical factors (homocysteine, triglycerides) demonstrated excellent calibration and clinical net benefit. Conclusion: Multimodal MRI radiomics combined with interpretable machine learning provides an accurate and explainable tool for AD diagnosis, with the combined LR model exhibiting superior performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.